Initial UK experience of stereotactic body radiotherapy for extracranial oligometastases: can we change the therapeutic paradigm?
K Aitken, A Tree, K Thomas, C Nutting, M Hawkins… - Clinical Oncology, 2015 - Elsevier
Aims To retrospectively review the toxicity and early outcome data from patients who have
received stereotactic body radiotherapy (SBRT) for extracranial oligometastases at a single
UK institution. Materials and methods Eligible patients had≤ 3 extracranial metastases and
performance status≤ 2. Prior systemic therapy and radical treatment of oligometastastic
relapse with any standard treatment modality was permitted. Patients with synchronous
metastatic disease were excluded unless they had evidence of controlled primary disease …
received stereotactic body radiotherapy (SBRT) for extracranial oligometastases at a single
UK institution. Materials and methods Eligible patients had≤ 3 extracranial metastases and
performance status≤ 2. Prior systemic therapy and radical treatment of oligometastastic
relapse with any standard treatment modality was permitted. Patients with synchronous
metastatic disease were excluded unless they had evidence of controlled primary disease …